Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Fallopian Tube Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Paclitaxel 3 mirvetuximab soravtansine 2 Bevacizumab 2 rucaparib 1 relacorilant 1 pembrolizumab 1 liposomal doxorubicin 1 Topotecan 1 Taxes 1 Saline Solution 1 Immunoglobulin G 1 Glucose 1 Docetaxel 1 Disulfides 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡